Showing results (541-550 of 660) with videos related to

Sort By:
Pageof 66
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 6, 2021
Lrp5 Mutant and Crispant Zebrafish Faithfully Model Human Osteoporosis, Establishing the Zebrafish as a Platform for CRISPR-Based Functional Screening of Osteoporosis Candidate GenesJan Willem Bek, Chen Shochat, Adelbert De Clercq, et al.
BMC Geriatrics|April 27, 2021
The prevalence and prescribing patterns of benzodiazepines and Z-drugs in older nursing home residents in different European countries and Israel: retrospective results from the EU SHELTER studyAnna Lukačišinová, Daniela Fialová, Nancye May Peel, et al.
Cancer Research|April 18, 2001
Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studiesA Trouet, A Passioukov, K Van derpoorten, et al.
Neurology|July 9, 2024
Association of Acute Incidental Cerebral Microinfarcts With Subsequent Ischemic Stroke in Patients With Cancer: A Population-Based StudyJonathan Naftali, Rani Barnea, Avi Leader, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1992
Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancerR F Meredith, M B Khazaeli, T Liu, et al.
Journal of the American Heart Association|December 21, 2020
Direct Admission of Patients With ST-Segment-Elevation Myocardial Infarction to the Catheterization Laboratory Shortens Pain-to-Balloon and Door-to-Balloon Time Intervals but Only the Pain-to-Balloon Interval Impacts Short- and Long-Term MortalitySimcha R Meisel, Michael Kleiner-Shochat, Rami Abu-Fanne, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1995
Potentiation of antiproliferative effects of monoclonal antibody Lym-1 and immunoconjugate Lym-1-gelonin on human Burkitt's lymphoma cells with gamma-interferon and tumor necrosis factorK P O'Boyle, D Colletti, C Mazurek, et al.
The Journal of Biological Chemistry|October 8, 2009
A combinatorial approach for the design of complementarity-determining region-derived peptidomimetics with in vitro anti-tumoral activityPeter Timmerman, Rodrigo Barderas, Johan Desmet, et al.
International Journal of Clinical Practice|December 30, 2016
Perception of prognosis of cancer patients by non-oncologistsHadar Goldvaser, Yonatan Milman, Tal Dujovni, et al.
Frontiers in Oncology|March 29, 2021
BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase InhibitorsElizabeth Dudnik, Jair Bar, Assaf Moore, et al.
Pageof 66